Can a 2-Month TB cocktail beat standard care?
NCT ID NCT05971602
First seen May 20, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study tested whether a shorter course (2 to 4 months) of a combination of TB drugs could safely and effectively treat adults with pulmonary tuberculosis. The trial included people with drug-sensitive and drug-resistant TB. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bio-Medical Research Institute; Faculty of Medicine and Health Sciences, Stellenbosch University; Tygerberg Medical Campus
Cape Town, South Africa
-
CHRU - Durban
Durban, South Africa
-
Clinical HIV Research Unit (CHRU) - Johannesburg
Johannesburg, South Africa
-
Lung Center of the Philippines
Quezon City, Philippines
-
Perinatal HIV Research Unit (PHRU)
Klerksdorp, South Africa
-
Silang Specialist Medical Center
Silang, Philippines
-
Synergy Biomed Research Institute
East London, South Africa
-
TASK - Central (Brooklyn)
Cape Town, South Africa
-
The Aurum Institute (Tembisa CRS)
Johannesburg, South Africa
-
Tropical Disease Foundation
Makati, Philippines
-
UCT (Cape Town); General Medicine & Global Health (GMGH); Hatter Heart Research Institute
Cape Town, South Africa
-
UCT South African Tuberculosis Vaccine Initiative (SATVI)
Cape Town, South Africa
-
University of Cape Town (UCT) Lung Institute
Cape Town, South Africa
Conditions
Explore the condition pages connected to this study.